After many very poor investment decisions i.e. Looksmart, Energy Developments, Bill Express and View Resources...finally, just finally I could be in for my biggest pay day yet.
The original Thoratec DT trial was for 200 patients at 38 centers. This one, 450 at 50 centers.
The next things to look out for are the enrolment (speed) data in the DT trial and the ability to get the MVAD trials up.
I agree Pat, doubling in the next 12 months is highly likely, given this news.
After many very poor investment decisions i.e. Looksmart, Energy...
Add to My Watchlist
What is My Watchlist?